In the media

Safer cells for immunotherapy

Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019

Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]

2019-02-13T05:02:22+00:00 February 13th, 2019|


Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc.

2019-01-22T00:16:09+00:00 January 21st, 2019|

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories–nci120418.php

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs


Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]

2018-12-20T02:44:33+00:00 December 20th, 2018|

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

Sydney Morning Herald (By Esther Han)

19 December 2018 — 12:00am

A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.

Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]

2018-12-20T00:05:33+00:00 December 19th, 2018|

The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System

An interview with UK immunologist Daniel Davis on national Public Radio’s “Fresh Air” is a good discussion about his new book for a general audience.

November 26, 20181:51 PM ET Heard on Fresh Air

Immunologist Daniel Davis says scientists are harnessing the power of the immune system to create new medications […]

2018-11-29T03:48:15+00:00 November 29th, 2018|